{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:18:19Z","timestamp":1772223499530,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T00:00:00Z","timestamp":1248307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Worldwide, proton pump inhibitors (PPI) are one of the most frequently prescribed drugs; however, up to 70% of patients taking these drugs have no appropriate indication. Although PPI are relatively well tolerated, they are not free from side\u2010effects and several life\u2010threatening complications are associated with them. In the present report, a 43\u2010year\u2010old woman presented to her general practitioner with an erythematous rash over her face and chest, having been started on omeprazole for chronic abdominal bloating. Over the next 24\u2003h she became increasingly unwell and was admitted to hospital with shortness of breath, pyrexia and the rash spreading over her back, arms and legs. Vesicles had now started to appear within the erythematous regions over her upper body and within 24\u2003h the rash became confluent and desquamative, spreading to involve her entire body. A diagnosis of toxic epidermal necrolysis (TEN) was made. Despite supportive treatment within a critical care setting, she became neutropaenic and her skin loss became more extensive, resulting in 95% epidermal detachment. This case highlights that TEN is a life\u2010threatening condition associated with a high incidence of morbidity and mortality. Optimal management requires early diagnosis and transfer to a specialized unit. Clinicians need to be aware that PPI are not free from side\u2010effects and that their routine prescription should be strongly discouraged.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2009.00540.x","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T04:45:58Z","timestamp":1248324358000},"page":"207-210","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Toxic epidermal necrolysis and neutropaenia: Complications of omeprazole"],"prefix":"10.1111","volume":"50","author":[{"given":"Avnesh S","family":"Thakor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailbhe","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Handfield\u2010Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayush","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alys","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39406.449456.BE"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1999.tb127696.x"},{"key":"e_1_2_5_4_2","first-page":"422","article-title":"Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome","volume":"17","author":"Petkov T","year":"2007","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_5_5_2","first-page":"15","article-title":"Adverse cutaneous reactions to drugs: an overview","volume":"42","author":"Sharma VK","year":"1996","journal-title":"J. Postgrad. Med."},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1990.01670250043005"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.41369"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00262.x"},{"key":"e_1_2_5_9_2","first-page":"699","article-title":"Toxic epidermal necrolysis due to omeprazole","volume":"16","author":"Casacci M","year":"2006","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01616.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02953.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92739-3"},{"key":"e_1_2_5_13_2","first-page":"353","article-title":"Lansoprazole\u2010induced subacute cutaneous lupus erythematosus: two cases","volume":"85","author":"Bracke A","year":"2005","journal-title":"Acta Derm. Venereol."},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7230.283"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0536.2001.440107-14.x","article-title":"Allergic contact dermatitis due to lansoprazole, a proton pump inhibitor","volume":"44","author":"Vilaplana J","year":"2001","journal-title":"Contact Dermatitis"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1157\/13059852"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.06.004"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01119.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2008.06.003"},{"key":"e_1_2_5_20_2","first-page":"7","article-title":"IVIG for the treatment of toxic epidermal necrolysis","volume":"12","author":"Mittmann N","year":"2007","journal-title":"Skin Therapy Lett."},{"key":"e_1_2_5_21_2","first-page":"1039","article-title":"Effects of treatments on the mortality of Stevens\u2010Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"23","author":"Schneck J","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-199809020-00014"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2009.00540.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2009.00540.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:37:06Z","timestamp":1697456226000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2009.00540.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,23]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1440-0960.2009.00540.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2009.00540.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,23]]},"assertion":[{"value":"2009-07-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}